CN104547434B - One treats chronic prostatitis Chinese medicine composition - Google Patents
One treats chronic prostatitis Chinese medicine composition Download PDFInfo
- Publication number
- CN104547434B CN104547434B CN201510081584.4A CN201510081584A CN104547434B CN 104547434 B CN104547434 B CN 104547434B CN 201510081584 A CN201510081584 A CN 201510081584A CN 104547434 B CN104547434 B CN 104547434B
- Authority
- CN
- China
- Prior art keywords
- medicine composition
- chinese medicine
- chronic prostatitis
- fructus
- crude drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 24
- 208000013507 chronic prostatitis Diseases 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000007909 solid dosage form Substances 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 210000002307 prostate Anatomy 0.000 abstract description 9
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 231100000614 poison Toxicity 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003440 toxic substance Substances 0.000 abstract description 5
- 239000002934 diuretic Substances 0.000 abstract description 3
- 230000001882 diuretic effect Effects 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 230000027939 micturition Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000019902 chronic diarrheal disease Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000002640 perineum Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010060891 General symptom Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010062903 Urethritis noninfective Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000010062 epididymo-orchitis Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The open one of the present invention treats chronic prostatitis Chinese medicine composition and preparation method thereof, belongs to tcm field.Be prepared from by the Chinese crude drug of following portions by weight: Radix Sophorae Tonkinensis 30-60, Semen Cuscutae 8-24, Fructus Schisandrae Chinensis 8-24, Rhizoma Dioscoreae 18-36, Carapax Trionycis 6-18, Fructus Gardeniae 30-60, Radix Astragali 6-18, Fructus Liquidambaris 6-18 and Radix Glycyrrhizae 6-18.The all medicines of the present invention with the use of, can complement each other, cooperative gain, plays the effect such as heat-clearing and toxic substances removing profit, diuretic dehumidifying, the kidney invigorating arresting seminal emission, hard masses softening and resolving, has therapeutic effect significantly to prostatitis, prostate hyperplasia.
Description
Technical field
The open one of the present invention treats chronic prostatitis Chinese medicine composition, belongs to tcm field.
Technical background
Prostate is the distinctive sexual glands of male, has the property secreting gland of inside and outside dual secretory function.Prostate morbidity not only can cause local do not accommodate symptom, the more important thing is, also can cause General Symptoms and discomfort, even cause the malignant disease such as uremia, tumor.
Along with the modern quickening of people's rhythm of life and the mixed and disorderly of dietary structure, prostatosis is rejuvenation gradually, and the sickness rate of person in middle and old age's prostatosis also progressively increases.The scorching disease in prostatitis occurs with premature ejaculation sometimes simultaneously, and the cardinal symptom of prostatic hyperplasia has dysuria, and the lighter's total urination time of getting up at night increases, and has urine retention or also has a small amount of phenomenon of discharging after having urinated; Severe patient occurs that urine stream attenuates, even the phenomenon of can not arranging; Same often with symptoms such as soreness of waist lumbago, myasthenia of limbs, seminal emissions.The harm of prostatosis to human body is many-sided, on short terms, can cause the untoward reaction such as insomnia and dreamful sleep, weak dizziness, lumbus sacrum pain, inappetence, nausea and vomiting.On long terms, pathogenic bacterium along the up infection of Posterior urethral, can cause Posterior urethral inflammation, also can follow deferent duct and come downwards to scrotum, bring out epididymo orchitis.
At present, the method for chemicals and operation is treatment prostatitis is Therapeutic Method the most frequently used at present, and easily repeatedly, weak effect, wound is large for right existing method.
Summary of the invention
It is high that the technical problem to be solved in the present invention is to provide a kind of cure rate, do not recur more, instant effect, the Chinese medicine composition of the treatment chronic prostatitis of short treating period.
For solving the problems of the technologies described above, inventor combines tcm clinical practice for many years and to practise medicine experience, is repeatedly verified and adjusts, provide a kind of Chinese medicine composition for the treatment of chronic prostatitis, it is characterized in that, be prepared from by the Chinese crude drug of following portions by weight by clinical practice:
Preferably, the present invention treats the Chinese medicine composition of chronic prostatitis, it is characterized in that, is prepared from by the Chinese crude drug of following portions by weight:
In Chinese medicine composition of the present invention Chinese medicine composition used, each composition pharmacology is as follows:
Radix Sophorae Tonkinensis:
[nature and flavor] are bitter, cold; Poisonous.
[return through] attaches to the lung and stomach meridians.
[function cures mainly] heat-clearing and toxic substances removing, detumescence sore-throat relieving.Pent up for fire-toxin, laryngopharynx swelling and pain, gingivitis.
Semen Cuscutae: [nature and flavor] are sweet, temperature.
[return through] returns liver,kidney,spleen warp.
[function cures mainly] nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, improving eyesight, antidiarrheal.For impotence and seminal emission, dripping urination, enuresis frequent micturition, soreness of the waist and knees, blurred vision tinnitus, vaginal bleeding due to deficiency of the kidney during pregnancy, frequent fetal movement, spleen is suffered from a deficiency of the kidney and is rushed down; Externally treating leucoderma.
Fructus Schisandrae Chinensis: [nature and flavor] are sour, sweet, temperature.
[return through] returns lung, the heart, kidney channel.
[function cures mainly] restrains astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming.For chronic cough dyspnea due to deficiency, emission, enuresis frequent micturition, incessant chronic diarrhea, spontaneous perspiration, night sweat, Tianjin wound is thirsty, and deficient pulse of losing heart, interior-heat is quenched one's thirst, palpitation and insomnia.
Rhizoma Dioscoreae: [nature and flavor] are sweet, flat.
[return through] returns spleen, lung, kidney channel.
[function cures mainly] spleen reinforcing nourishing the stomach, promote the production of body fluid lung benefiting, the kidney invigorating arresting seminal emission.For insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung is breathed with cough, emission due to deficiency of the kidney, leukorrhagia, frequent micturition, and deficiency-heat is quenched one's thirst.Rhizoma Dioscoreae (parched with bran) spleen reinforcing stomach invigorating.For insufficiency of the spleen lack of appetite, loose stool of having loose bowels, leukorrhagia.
Carapax Trionycis: [nature and flavor] are salty, are slightly cold.
[return through] returns liver, kidney channel.
[function cures mainly] nourishing YIN for suppressing the hyperactive YANG, hard masses softening and resolving, brings down a fever except steaming.For fever due to yin deficiency, consumptive fever hectic fever due to YIN-deficiency, stirring-up of pathogenic wind in the interior resulting from deficiency, amenorrhea ， WEIJIA, chronic malaria malaria with splenomegaly
Fructus Gardeniae: [nature and flavor] are bitter, cold.
[return through] GUIXIN, lung, tri-jiao channel.
[function cures mainly] fruit: pathogenic fire purging relieving restlessness, clearing away heat and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body.Vexed for calentura, jaundice dark coloured urine, blood strangury and dry pain, heat in blood tells nosebleed, conjunctival congestion and swelling pain, pathogenic fire,toxin and furuncles; External treatment bruise pain.
The Radix Astragali: [nature and flavor] are sweet, temperature.
[return through] returns lung, spleen channel.
[function cures mainly] invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.Weak for the deficiency of vital energy, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy edema, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency dull yellowish colored skin, interior-heat is quenched one's thirst; Chronic nephritis proteinuria, diabetes.
Fructus Liquidambaris: [nature and flavor] are bitter is flat.
[return through] returns liver, kidney channel.
[function cures mainly] dispelling, collateral-activating, diuretic stimulates the menstrual flow.For arthralgia, numbness contracture, edema distension, the few amenorrhea of breast.
Radix Glycyrrhizae: [nature and flavor] are sweet, flat.
[return through] GUIXIN, lung, spleen, stomach warp.
[function cures mainly] invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, the anxious pain of gastral cavity abdomen, extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Present invention also offers a kind of preparation method for the treatment of chronic prostatitis Chinese medicine composition, it is characterized in that comprising following steps:
(1), in prescription ratio each taste Chinese crude drug is accurately taken, for subsequent use.
(2), by Radix Sophorae Tonkinensis, Semen Cuscutae, Fructus Schisandrae Chinensis, Fructus Gardeniae, Fructus Liquidambaris grind respectively, add the purified water of medical material 5-10 times weight, soak 0.5-2 hour, decoct 1-3 hour, filter; Filtering residue adds 3-5 times of water gaging, decocts 1-3 hour; Filter, merge twice filtrate; Concentrated filtrate, dry, pulverize into 80 object fine powders, for subsequent use.
(3), by Rhizoma Dioscoreae, Carapax Trionycis, the Radix Astragali, Radix Glycyrrhizae mixing, 80 object fine powders were ground into, for subsequent use.
(4), by step 3 and step 4 gained fine powder mix homogeneously, sterilizing is prepared into the solid dosage formss such as tablet, powder, pill, granule or capsule.
The all medicines of the present invention with the use of, can complement each other, cooperative gain, plays the effect such as heat-clearing and toxic substances removing profit, diuretic dehumidifying, the kidney invigorating arresting seminal emission, hard masses softening and resolving, has therapeutic effect significantly to prostatitis, prostate hyperplasia.
Compared with prior art, the present invention treats chronic prostatitis Chinese medicine composition, and to have cure rate high, do not recur, instant effect more, and short treating period, safety is high, dosage is low, the advantages such as no side effects.And its preparation method is simple, be easy to apply.
Clinical data
1. physical data
Chronic prostatitis case 120 example selecting here over-2014 years in 2012 medical.Be divided into treatment group and matched group at random, treatment group 60 example, age 26-61 year, average 42.2 years old; The course of disease 11 months-8 years, average 4.2 years; Matched group 60 example, age 26-60 year, average 42.8 years old; The course of disease 10 months-9 years, average 4.5 years.
Above patient's main clinical manifestation: urethral symptom refer to frequent micturition, urgent micturition, dysurea and the heeltap not to the utmost, drip after urine white; Local distending pain refers to perineal position distending pain or companion's lumbago and backache; General Symptoms finger is dizzy, weak, the symptoms such as insomnia.
Two groups of cases are all through body of prostate ultrasound diagnosis, and result all cases all has echo to change, skewness, and edge is irregular, prompting chronic prostatitis, and all cases per rectum refers to inspection, all points out chronic prostatitis;
Through statistical analysis, between two groups, the difference such as age, the state of an illness, the course of disease is little, has comparability.
2. diagnostic criteria
Press hydraulic fluid microscopy 3 according to patient's medical history, clinical symptoms, prostate palpation, prostate, possessing 2 persons can make a definite diagnosis.
Clinical symptoms:
1) paruria: urethral orifice adularescent mucoid secretions when frequent micturition, urgent micturition, dysurea, dribble of urine, urine end or stool, urethra scorching hot, scratchy and urinate not smooth (possessing more than 3);
2) local pain: perineum genital area, lower abdomen suprapubic region, lumbosacral region (at least one position continues more than 3 months).Prostate palpation (anus refers to inspection): Prostatic Surface is uneven, or asymmetric, and quality soft or hard is uneven, maybe can touch inflammatory tubercle, have local tenderness.Prostate is by hydraulic fluid microscopy: every high power field leukocyte is more than more than 10, and lecithin reduces or disappears.
3. Therapeutic Method
Treatment group: capsule prepared by the oral embodiment of the present invention 1, every day 2 times, each 4-6 grain.A course for the treatment of 4 Mondays, treat 2 courses for the treatment of continuously.
Matched group: oral QIANLIEKANG PIAN, every day 3 times, one time 3 ~ 4, continuously 2 courses for the treatment of of treatment.
4, criterion of therapeutical effect
According to chronic prostatitis criterion of therapeutical effect evaluation relevant in " disease clinical diagnosis and criterion of therapeutical effect ", cure: transference cure, 3 massage liquid inspections are all normal, B ultrasonic and digital rectal examination normal; Take a turn for the better: symptom is improved, massage liquid checks leukocyte < 10/HP, lecithin > 10/HP, and pyocyte disappears, and B ultrasonic and digital rectal examination show that mild inflammatory changes; Invalid: treatment before and after symptom, check unchanged.
5, therapeutic outcome
Two groups of comparitive study are in table 1.
Table 1 liang group comparitive study
| Group | Case load | Cure (cure rate) | Take a turn for the better (improvement rate) | Invalid (inefficiency) | Total effective rate |
| Matched group | 60 | 8(13.3％) | 40(66.7％) | 12(20.0％) | 80.0％ |
| Treatment group | 60 | 25(41.7％) | 33(55.5％) | 2(3.3％) | 96.7％ |
Two groups are compared, and treatment group cure rate, total effective rate, be obviously better than matched group, has significant, have comparability (P < 0.05).Wherein matched group 8 cures patient, after drug withdrawal half a year, and recurrence 4 example; Treatment group 25 example cures patient, and after drug withdrawal half a year, no case was recurrence.Visible the present invention's treatment chronic prostatitis Chinese medicine composition is better than existing medicine QIANLIEKANG PIAN, and have cure rate high, the advantage do not recurred more, therapeutic effect is very remarkable.
Model case
Case 1: Wang, 50 years old, over nearly 1 year, often feel that the soreness of waist, urine are unclean, nocturia increased, and perineum and lower abdomen are done swollen, lustreless complexion, and white and greasy fur is thicker, and matter is light, and thready pulse chi is soft, is diagnosed as prostatitis; Take Chinese medicine composition of the present invention, two courses for the treatment of, its various transference cure, reaches criterion of cure, continues to strengthen and takes medicine 2 weeks, follows up a case by regular visits to half a year without recurrence.
Case 2: together certain, 65 years old, private prosecution suffers from chronic prostatitis 6 years, adopted various Therapeutic Method all invalid, urethral orifice adularescent mucoid secretions when cardinal symptom has frequent micturition, urgent micturition, dysurea, dribble of urine, urine end or defecates, the positions such as perineum genital area, lower abdomen suprapubic region, lumbosacral region, regular have pain.Take Chinese medicine composition of the present invention, two courses for the treatment of, its various symptom is clearly better, and continues 1 course for the treatment of of taking medicine, and its various transference cure, reaches criterion of cure, continues to strengthen and takes medicine 2 weeks, follows up a case by regular visits to half a year without recurrence.
Detailed description of the invention
The preparation of embodiment 1 capsule
Be prepared from by the Chinese crude drug of following portions by weight:
Preparation method:
(1), in above-mentioned prescription ratio each taste Chinese crude drug is accurately taken, for subsequent use.
(2), by Radix Sophorae Tonkinensis, Semen Cuscutae, Fructus Schisandrae Chinensis, Fructus Gardeniae, Fructus Liquidambaris grind respectively, add the purified water of medical material 8 times of weight, soak 1 hour, decoct 2 hours, filter; Filtering residue adds 5 times of water gagings, decocts 1 hour; Filter, merge twice filtrate; Concentrated filtrate, dry, pulverize into 80 object fine powders, for subsequent use.
(3), by Rhizoma Dioscoreae, Carapax Trionycis, the Radix Astragali, Radix Glycyrrhizae mixing, 80 object fine powders were ground into, for subsequent use.
(4), by step 3 and step 4 gained fine powder mix homogeneously, sterilizing, loads capsule, and every containing crude drug 0.4g.
The preparation of embodiment 2 tablet
Be prepared from by the Chinese crude drug of following portions by weight:
Preparation method:
(1), in above-mentioned prescription ratio each taste Chinese crude drug is accurately taken, for subsequent use.
(2), by Radix Sophorae Tonkinensis, Semen Cuscutae, Fructus Schisandrae Chinensis, Fructus Gardeniae, Fructus Liquidambaris grind respectively, add the purified water of medical material 10 times of weight, soak 2 hours, decoct 3 hours, filter; Filtering residue adds 5 times of water gagings, decocts 1 hour; Filter, merge twice filtrate; Concentrated filtrate, dry, pulverize into 80 object fine powders, for subsequent use.
(3), by Rhizoma Dioscoreae, Carapax Trionycis, the Radix Astragali, Radix Glycyrrhizae mixing, 80 object fine powders were ground into, for subsequent use.
(4), by step 3 and step 4 gained fine powder mix homogeneously, sterilizing, is prepared into tablet.
The preparation of embodiment 3 granule
Be prepared from by the Chinese crude drug of following portions by weight:
Preparation method:
(1), in prescription ratio each taste Chinese crude drug is accurately taken, for subsequent use.
(2), by Radix Sophorae Tonkinensis, Semen Cuscutae, Fructus Schisandrae Chinensis, Fructus Gardeniae, Fructus Liquidambaris grind respectively, add the purified water of medical material 8 times of weight, soak 0.5 hour, decoct 1 hour, filter; Filtering residue adds 3 times of water gagings, decocts 1 hour; Filter, merge twice filtrate; Concentrated filtrate, dry, pulverize into 80 object fine powders, for subsequent use.
(3), by Rhizoma Dioscoreae, Carapax Trionycis, the Radix Astragali, Radix Glycyrrhizae mixing, 80 object fine powders were ground into, for subsequent use.
(4), by step 3 and step 4 gained fine powder mix homogeneously, sterilizing is prepared into granule.
The preparation of embodiment 4 pill
Be prepared from by the Chinese crude drug of following portions by weight:
Preparation method:
(1), in prescription ratio each taste Chinese crude drug is accurately taken, for subsequent use.
(2), by Radix Sophorae Tonkinensis, Semen Cuscutae, Fructus Schisandrae Chinensis, Fructus Gardeniae, Fructus Liquidambaris grind respectively, add the purified water of medical material 5-10 times weight, soak 0.5-2 hour, decoct 1-3 hour, filter; Filtering residue adds 3-5 times of water gaging, decocts 1-3 hour; Filter, merge twice filtrate; Concentrated filtrate, dry, pulverize into 80 object fine powders, for subsequent use.
(3), by Rhizoma Dioscoreae, Carapax Trionycis, the Radix Astragali, Radix Glycyrrhizae mixing, 80 object fine powders were ground into, for subsequent use.
(4), by step 3 and step 4 gained fine powder mix homogeneously, sterilizing, adds refined honey, is prepared into pill.
Claims (4)
1. treat a Chinese medicine composition for chronic prostatitis, it is characterized in that, be prepared from by the Chinese crude drug of following portions by weight:
2. the Chinese medicine composition for the treatment of chronic prostatitis according to claim 1, is characterized in that, is prepared from by the Chinese crude drug of following portions by weight:
3. the Chinese medicine composition for the treatment of chronic prostatitis according to claim 1 and 2, is characterized in that preparation method comprises following steps:
(1) each taste Chinese crude drug is accurately taken in prescription ratio, for subsequent use;
(2) Radix Sophorae Tonkinensis, Semen Cuscutae, Fructus Schisandrae Chinensis, Fructus Gardeniae, Fructus Liquidambaris are ground respectively, add the purified water of medical material 5-10 times weight, soak 0.5-2 hour, decoct 1-3 hour, filter; Filtering residue adds 3-5 times of water gaging, decocts 1-3 hour; Filter, merge twice filtrate; Concentrated filtrate, dry, pulverize into 80 object fine powders, for subsequent use;
(3) by Rhizoma Dioscoreae, Carapax Trionycis, the Radix Astragali, Radix Glycyrrhizae mixing, 80 object fine powders were ground into, for subsequent use;
(4) by step (2) and step (3) gained fine powder mix homogeneously, sterilizing is prepared into solid dosage forms.
4. the Chinese medicine composition for the treatment of chronic prostatitis according to claim 1 and 2, is characterized in that, described Chinese medicine composition is tablet, powder, pill, granule or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510081584.4A CN104547434B (en) | 2015-02-15 | 2015-02-15 | One treats chronic prostatitis Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510081584.4A CN104547434B (en) | 2015-02-15 | 2015-02-15 | One treats chronic prostatitis Chinese medicine composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104547434A CN104547434A (en) | 2015-04-29 |
| CN104547434B true CN104547434B (en) | 2016-03-23 |
Family
ID=53065205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510081584.4A Expired - Fee Related CN104547434B (en) | 2015-02-15 | 2015-02-15 | One treats chronic prostatitis Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104547434B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107198755A (en) * | 2017-06-15 | 2017-09-26 | 合肥川迪医药技术有限公司 | One kind treats prostatitic Chinese medicine and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1733197A (en) * | 2005-08-24 | 2006-02-15 | 王少金 | Medicine for curing chronic prostatitis and process for preparing the same |
| CN102631415A (en) * | 2011-03-01 | 2012-08-15 | 四川升和药业股份有限公司 | Traditional Chinese medicine composite as well as product and application thereof |
| CN102671094A (en) * | 2012-05-13 | 2012-09-19 | 刘天岐 | Liquorice pill for tonifying spleen and kidney |
-
2015
- 2015-02-15 CN CN201510081584.4A patent/CN104547434B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1733197A (en) * | 2005-08-24 | 2006-02-15 | 王少金 | Medicine for curing chronic prostatitis and process for preparing the same |
| CN102631415A (en) * | 2011-03-01 | 2012-08-15 | 四川升和药业股份有限公司 | Traditional Chinese medicine composite as well as product and application thereof |
| CN102671094A (en) * | 2012-05-13 | 2012-09-19 | 刘天岐 | Liquorice pill for tonifying spleen and kidney |
Non-Patent Citations (1)
| Title |
|---|
| 中医治疗慢性前列腺炎近况;司福全;《云南中医中药杂志》;20100731;第31卷(第7期);79-81 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104547434A (en) | 2015-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103751521B (en) | A kind of medicine for the treatment of habitual constipation | |
| CN101700393B (en) | Traditional Chinese medicine composition for treating breast cancer | |
| CN104857478A (en) | Medical composition for treating hysteromyoma and preparation method of medical composition | |
| CN104491831A (en) | Traditional Chinese preparation used for treating compact sacrum and ilium arthritis and preparation method of traditional Chinese preparation | |
| CN102580011B (en) | Navel fumigating traditional Chinese medicine composition for treating prostatitis | |
| CN105012772A (en) | Traditional Chinese medicine preparation for rectal prolapses and preparation method of preparation | |
| CN104288631A (en) | Medicine composition for treating colon cancer and preparation method thereof | |
| CN105031331B (en) | A kind of navel patch and preparation method thereof for treating dysmenorrhea | |
| CN103638234B (en) | A kind of Chinese medicine composition, preparation and preparation method thereof for the treatment of tinnitus | |
| CN104547434B (en) | One treats chronic prostatitis Chinese medicine composition | |
| CN104189695A (en) | Chinese herbal medicine preparation for treating uroclepsia and preparation method thereof | |
| CN103142890B (en) | Traditional Chinese medicine composition for treating phlegm-damp internal resistance type irregular menstruation | |
| CN101036742B (en) | Medicine for treating prostatic disease | |
| CN105079374B (en) | A kind of Chinese medicine composition for treating dysmenorrhoea | |
| CN104258275A (en) | Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis | |
| CN103656063A (en) | Medicine for treating chronic prostatitis | |
| CN104096035A (en) | Traditional Chinese medicine composition for treating hernia | |
| CN104721453B (en) | A kind of bellybutton-applying plaster of catharsis and toxin expelling and preparation method thereof, application method | |
| CN104491753A (en) | Detoxifying preparation for treating damp-heat toxin accumulated type cholecystitis and preparation method of detoxifying preparation | |
| CN104383417A (en) | Medicine for curing breast cancer | |
| CN104352846A (en) | Traditional Chinese medicinal composition for treating senile constipation | |
| CN102178917B (en) | Chinese medicinal composition for treating qi channelling | |
| CN104645185B (en) | A kind of Chinese traditional medicine composition for treating the qi-deficiency type retention of urine | |
| CN104721638A (en) | Traditional Chinese medicine preparation used for treating prostatitis | |
| CN104173995A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Kexia Inventor before: Wang Guixia |
|
| COR | Change of bibliographic data | ||
| GR01 | Patent grant | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160301 Address after: 276401, Yimeng Shandong Road 27, Yishui Town, Yishui County, Shandong, Linyi Applicant after: Wang Kexia Address before: 276401 Yishui City, Linyi province Yishui County town of new lane, No. 18 Applicant before: Wang Guixia |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160323 Termination date: 20170215 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |